Recalls

All Class I Class II Class III

1,723 recalls

III Magnesium Chloride, 6-Hydrate, Crystal, 500G per bottle, Bulk active pharmaceutical ingredient (API), Avantor Performanc… Subpotent drug Avantor Performance Materials LLC · Apr 22, 2026 III Essential Calming Skin Gel, hydrocortisone 1%, 120mL/4oz net wt. (113g) per jar, Distributed By: A.C.E. Inc., DFW Intl. Subpotent Drug Island Kinetics, Inc. d.b.a. CoValence Laboratories · Apr 22, 2026 III Skin Rehab, Calming Skin Gel, Hydrocortisone Balm, hydrocortisone 1%, .53oz net wt. Subpotent Drug Island Kinetics, Inc. d.b.a. CoValence Laboratories · Apr 22, 2026 III Remedy Gel, hydrocortisone 1%, 30 mL/ 1 fl oz per bottle, Distributed By: glo Skin Beauty, Denver, CO 80216. Subpotent Drug Island Kinetics, Inc. d.b.a. CoValence Laboratories · Apr 22, 2026 III Gelatin Capsule Pack for use with the Sodium Iodide I-131 Kit (containing 5 empty capsules and 5 Dibasic Sodium Phosphat… Failed Tablet/Capsule Specifications Radnostix · Apr 1, 2026 III Pitavastatin Tablets, 2 mg, packaged in 90-count bottles, Rx only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141… Presence of foreign tablets/capsules: one Pitavastatin tablet 1mg found in bottle of Pitavastatin tablets 2mg Annora Pharma Private Limited · Mar 25, 2026 III Nilotinib Capsules, 200 mg per capsule, packaged in cartons, Rx only, Manufactured for: Cipla USA, Inc., 10 Independence… Failed Tablet/Capsule Specifications: Observed OOS results at 6-months long-term stability condition for Description tes… Cipla USA, Inc. · Mar 11, 2026 III Nilotinib Capsules, 150 mg per capsule, packaged in cartons, Rx only, Manufactured by: Cipla Ltd., Verna, Goa, India, Ma… Failed Tablet/Capsule Specifications: Observed OOS results at 6-months long-term stability condition for Description tes… Cipla USA, Inc. · Mar 11, 2026 III Eptifibatide Injection, 75 mg/100 mL vial for weight-adjusted bolus dosing, 1x100 mL Single-dose Vial, For Intravenous U… Labeling: Not Elsewhere Classified. The carton for Eptifibatide Injection 75 mg/100 mL states 75 mg/100 mL vial for weig… Slate Run Pharmaceuticals · Mar 4, 2026 III Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceuticals (USA), Inc., 1 To… Tablets/Capsules Imprinted with Wrong ID Unichem Pharmaceuticals USA Inc. · Feb 18, 2026 III Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN Pharmaceuticals Inc., Piscataway… Failed Impurities/Degradation Specifications Novadoz Pharmaceuticals Llc · Feb 4, 2026 III parodontax (cetylpyridinium chloride)ACTIVE GUM HEALTH, Mouthwash, Mint. Labeling: Incorrect or Missing Lot and/or Exp Date: Potential for missing or illegible lot and expiration date coding on… Haleon US Holdings LLC · Feb 4, 2026 III Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd., 307 E Josephine Stre… Failed PH Specifications Cipla USA, Inc. · Jan 28, 2026 III Clindamycin Phosphate USP, 1% (10 mg/mL), Topical Solution, 60 mL per applicator bottle, Rx only, Mfd. Failed Impurities/Degradation: Out of Specification results for Total Impurities and for Assay. Sun Pharmaceutical Industries Inc · Jan 21, 2026 III Fluocinolone Acetonide Solution Topical Solution USP, 0.01%, 60-mL bottles, Rx only, Dist. Failed Impurities/Degradation Specifications: Out of specification result was obtained for the known impurity D. Sun Pharmaceutical Industries Inc · Jan 21, 2026 III Fesoterodine Fumarate, Extended-release Tablets, 8 mg, 30 Tablets, Rx only, Manufactured by: Alembic Pharmaceuticals Lim… Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit. Alembic Pharmaceuticals Limited · Jan 14, 2026 III traZODONE Hydrochloride Tablets, USP, 100mg, 1,000 Tablets, Rx only, Manufactured by: Zydus Lifesciences Ltd., India, Di… Failed Tablet/Capsule Specifications: Product complaint received that some tablets had a dent on the plain side of the t… Zydus Pharmaceuticals (USA) Inc · Jan 7, 2026 III Cisatracurium Besylate Injection USP, 20 mg/10 mL*,(2 mg/mL), 10 x 10 mL Multiple-dose Vials per carton, Rx Only, Manufa… Subpotent product:out of specification assay results observed during long term stability testing. Somerset Therapeutics Llc · Dec 24, 2025 III Cisatracurium Besylate Injection USP, 200mg/20mL*(10mg/mL), 10 x 20 mL Single-dose Vials per Carton, Rx Only, Manufactur… Subpotent product:out of specification assay results observed during long term stability testing. Somerset Therapeutics Llc · Dec 24, 2025 III Cisatracurium Besylate Injection USP, 10 mg/5 mL* (2mg/mL), 10 x 5 mL Single-dose Vials per Carton, Rx Only, Manufacture… Subpotent product:out of specification assay results observed during long term stability testing. Somerset Therapeutics Llc · Dec 24, 2025